These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15606836)

  • 41. Localized diffuse melanosis associated with melanoma successfully treated with imiquimod cream 5%: a case report and review of the literature.
    Fields K; Milikowski C; Jewell T; Fields J
    Cutis; 2014 Mar; 93(3):145-50. PubMed ID: 24738096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of imiquimod in skin cancer treatment.
    Urosevic M; Dummer R
    Am J Clin Dermatol; 2004; 5(6):453-8. PubMed ID: 15663342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Periocular Melanoma In Situ Treated With Imiquimod.
    Elia MD; Lally SE; Hanlon AM; Choi JN; Servat JJ; Shields JA; Shields CL; Levin F
    Ophthalmic Plast Reconstr Surg; 2016; 32(5):371-3. PubMed ID: 26325381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [How I treat ... lentigo maligna by topical imiquimod].
    Bourguignon R; Paquet P; Quatresooz P; Piérard GE
    Rev Med Liege; 2005 Sep; 60(9):691-4. PubMed ID: 16265961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
    Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
    Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream.
    Chapman MS; Spencer SK; Brennick JB
    Arch Dermatol; 2003 Jul; 139(7):943-4. PubMed ID: 12873902
    [No Abstract]   [Full Text] [Related]  

  • 47. [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
    Elfatoiki FZ; Longvert C; Clerici T; Bourgault-Villada I; Roudier-Pujol C; Vasseur E; Saiag P
    Ann Dermatol Venereol; 2014 Feb; 141(2):106-10. PubMed ID: 24507204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream.
    Weisberg NK; Varghese M
    Dermatol Surg; 2002 Jun; 28(6):518-23. PubMed ID: 12081683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil].
    Florin V; Vercambre-Darras S; Piette F; Mortier L
    Ann Dermatol Venereol; 2008; 135(8-9):603-4. PubMed ID: 18789300
    [No Abstract]   [Full Text] [Related]  

  • 50. Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells.
    Savarese I; Papi F; D'Errico A; Gori A; Grazzini M; Vannucchi M; Massi D; De Giorgi V
    Clin Exp Dermatol; 2015 Jan; 40(1):27-30. PubMed ID: 25252087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance].
    Lorentzen HF; Weismann K
    Ugeskr Laeger; 2005 Sep; 167(39):3696-7. PubMed ID: 16219219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream.
    Garcia MS; Ono Y; Martinez SR; Chen SL; Goodarzi H; Phan T; Wehrli LN; Miyamura Y; Fung MA; Maverakis E
    Melanoma Res; 2011 Jun; 21(3):235-43. PubMed ID: 21464773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
    Stockfleth E; Meyer T; Benninghoff B; Christophers E
    Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
    Gill VL; Bergman PJ; Baer KE; Craft D; Leung C
    Vet Comp Oncol; 2008 Mar; 6(1):55-64. PubMed ID: 19178663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
    Marks R; Owens M; Walters SA;
    Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
    [No Abstract]   [Full Text] [Related]  

  • 57. Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma.
    Martín-García RF
    Dermatol Surg; 2005 Mar; 31(3):371-4. PubMed ID: 15841646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of lymphangioma circumscriptum with topical imiquimod 5% cream.
    Wang JY; Liu LF; Mao XH
    Dermatol Surg; 2012 Sep; 38(9):1566-9. PubMed ID: 22805499
    [No Abstract]   [Full Text] [Related]  

  • 59. Topical imiquimod in the treatment of metastatic melanoma to skin.
    Wolf IH; Smolle J; Binder B; Cerroni L; Richtig E; Kerl H
    Arch Dermatol; 2003 Mar; 139(3):273-6. PubMed ID: 12622616
    [No Abstract]   [Full Text] [Related]  

  • 60. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.